Press Releases

Date Title and Summary View
Toggle Summary NxStage and Satellite Healthcare Announce New Three-Year Home Hemodialysis Agreement that Includes Innovative Nx2me Platform
LAWRENCE, Mass. , Oct. 3, 2016 /PRNewswire/ --  NxStage Medical, Inc.  (Nasdaq: NXTM),  a leading medical technology company focused on advancing renal care , today announced a three-year agreement with Satellite Healthcare that includes NxStage's innovative Nx2me Connected Health® platform
View HTML
Toggle Summary NxStage Launches First of Many NxGen Features and Capabilities
LAWRENCE, Mass. , Aug. 8, 2016 NxStage Medical , Inc. (Nasdaq: NXTM),  a leading manufacturer of dialysis products , today announced the release of new enhanced priming features, the first of many upcoming capabilities of its next generation hemodialysis system.  The features are designed to be
View HTML
Toggle Summary NxStage Reports Second Quarter Financial Results And Raises Full-Year Revenue Guidance
-- Revenue Increases to $92.2 million, up 15% from Q2'15-- Home Revenue Increases to $51.1 million, up 14% from Q2'15-- Operating Income from Products Business Increases to $5.0 million-- Full-Year Revenue Guidance Increases to $360 to $365 million-- Company Launches First of Many NxGen Features and Capabilities
View HTML
Toggle Summary NxStage to Present at Canaccord Genuity 36th Annual Growth Conference
LAWRENCE, Mass. , Aug. 2, 2016 /PRNewswire/ --  NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that Jeffrey H. Burbank , Chief Executive Officer, and Matthew Towse , Chief Financial Officer, will present at the Canaccord
View HTML
Toggle Summary Macon Dialysis Center Grand Opening
LAWRENCE, Mass. , July 21, 2016 /PRNewswire/ -- NxStage Kidney Care, Inc., a subsidiary of NxStage Medical, Inc. (Nasdaq: NXTM), is pleased to announce the grand opening of its Macon dialysis center, known as Georgia Kidney Institute ("GKI"). "We aim to give patients their autonomy back by
View HTML
Toggle Summary NxStage® to Report Second Quarter 2016 Financial Results
LAWRENCE, Mass. , July 1, 2016 /PRNewswire/ --  NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care , today announced plans to release its financial results for the second quarter ended June 30, 2016 , on Thursday, August 4, 2016 , before the
View HTML
Toggle Summary NxStage Announces Second Quarter 2016 Investor Conference Schedule
LAWRENCE, Mass. , May 24, 2016 /PRNewswire/ --  NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that Jeffrey H. Burbank , Chief Executive Officer, plans to participate in the following schedule of investor conferences.
View HTML
Toggle Summary NxStage Reports First Quarter Financial Results
-- Revenue Increases to $89.2 million, up 12% from Q1'15-- Home Revenue Increases to $49.5 million, up 14% from Q1'15-- Operating Income from Products Business Increases to $6.2 million-- Total Revenue Guidance for 2016 Moves to High End of Previous Guidance Range
View HTML
Toggle Summary NxStage to Present at the Deutsche Bank 41st Annual Health Care Conference
LAWRENCE, Mass. , April 25, 2016 /PRNewswire/ --  NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that Jeffrey H. Burbank , Chief Executive Officer, plans to present at the Deutsche Bank 41 st Annual Health Care Conference
View HTML
Toggle Summary NxStage Kidney Care Opens New Dialysis Centers in Baltimore, Maryland
Locations in Linthicum Heights and Timonium offer personalized home and in-center care
View HTML